Correlation Between TC BioPharm and BioAffinity Technologies

Can any of the company-specific risk be diversified away by investing in both TC BioPharm and BioAffinity Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TC BioPharm and BioAffinity Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between TC BioPharm plc and bioAffinity Technologies Warrant, you can compare the effects of market volatilities on TC BioPharm and BioAffinity Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TC BioPharm with a short position of BioAffinity Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of TC BioPharm and BioAffinity Technologies.

Diversification Opportunities for TC BioPharm and BioAffinity Technologies

0.11

Correlation Coefficient

TC BioPharm  BioAffinity Technologies

Average diversification

The 3 months correlation between TCBPW and BioAffinity is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding TC BioPharm plc and bioAffinity Technologies Warra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioAffinity Technologies and TC BioPharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TC BioPharm plc are associated (or correlated) with BioAffinity Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioAffinity Technologies has no effect on the direction of TC BioPharm i.e., TC BioPharm and BioAffinity Technologies go up and down completely randomly.

Pair Corralation between TC BioPharm and BioAffinity Technologies

Assuming the 90 days horizon TC BioPharm is expected to generate 2.04 times less return on investment than BioAffinity Technologies. But when comparing it to its historical volatility, TC BioPharm plc is 1.25 times less risky than BioAffinity Technologies. It trades about 0.03 of its potential returns per unit of risk. bioAffinity Technologies Warrant is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  30.00  in bioAffinity Technologies Warrant on December 30, 2024 and sell it today you would lose (6.00) from holding bioAffinity Technologies Warrant or give up 20.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	83.93%
Values	Daily Returns

TC BioPharm plc  vs.  bioAffinity Technologies Warra

TC BioPharm plc

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in TC BioPharm plc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, TC BioPharm showed solid returns over the last few months and may actually be approaching a breakup point.

BioAffinity Technologies

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in bioAffinity Technologies Warrant are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, BioAffinity Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with TC BioPharm and BioAffinity Technologies

The main advantage of trading using opposite TC BioPharm and BioAffinity Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TC BioPharm position performs unexpectedly, BioAffinity Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies will offset losses from the drop in BioAffinity Technologies' long position.

The idea behind TC BioPharm plc and bioAffinity Technologies Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.